This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2006 Sep;29(9):2114-6.

doi: 10.2337/dc06-1136.

Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050

K M Venkat Narayan¹, James P Boyle, Linda S Geiss, Jinan B Saaddine, Theodore J Thompson

Affiliations

PMID: 16936162
DOI: 10.2337/dc06-1136

Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050

K M Venkat Narayan et al. Diabetes Care. 2006 Sep.

. 2006 Sep;29(9):2114-6.

doi: 10.2337/dc06-1136.

Authors

K M Venkat Narayan¹, James P Boyle, Linda S Geiss, Jinan B Saaddine, Theodore J Thompson

Affiliation

¹ Division of Diabetes Translation, Centers for Disease Control and Prevention, 4770 Buford Highway NE, MS K-10, Atlanta, GA 30341-3717, USA. kav4@cdc.gov

PMID: 16936162
DOI: 10.2337/dc06-1136

No abstract available

PubMed Disclaimer

Similar articles

Diabetes mellitus and life insurance.
Milano AF. Milano AF. J Insur Med. 2001;33(1):50-103. J Insur Med. 2001. PMID: 11317882 Review.
Diabetes--prevalence and cost of illness in Germany: a study evaluating data from the statutory health insurance in Germany.
Stock SA, Redaelli M, Wendland G, Civello D, Lauterbach KW. Stock SA, et al. Diabet Med. 2006 Mar;23(3):299-305. doi: 10.1111/j.1464-5491.2005.01779.x. Diabet Med. 2006. PMID: 16492214
The direct medical cost of diabetes in Israel.
Chodick G, Heymann AD, Wood F, Kokia E. Chodick G, et al. Eur J Health Econ. 2005 Jun;6(2):166-71. doi: 10.1007/s10198-004-0269-7. Eur J Health Econ. 2005. PMID: 15690168
Diabetes: prevalence and economic implications.
[No authors listed] [No authors listed] Manag Care. 2000 Aug;9(8 Suppl):2-4. Manag Care. 2000. PMID: 11729414 No abstract available.
Economic costs of diabetes in the U.S. In 2007.
American Diabetes Association. American Diabetes Association. Diabetes Care. 2008 Mar;31(3):596-615. doi: 10.2337/dc08-9017. Diabetes Care. 2008. PMID: 18308683 Review.

See all similar articles

Cited by

Microaneurysm turnover at the macula predicts risk of development of clinically significant macular edema in persons with mild nonproliferative diabetic retinopathy.
Ribeiro ML, Nunes SG, Cunha-Vaz JG. Ribeiro ML, et al. Diabetes Care. 2013 May;36(5):1254-9. doi: 10.2337/dc12-1491. Epub 2012 Nov 30. Diabetes Care. 2013. PMID: 23204247 Free PMC article.
Long-Term Safety of Dapagliflozin in Older Patients with Type 2 Diabetes Mellitus: A Pooled Analysis of Phase IIb/III Studies.
Fioretto P, Mansfield TA, Ptaszynska A, Yavin Y, Johnsson E, Parikh S. Fioretto P, et al. Drugs Aging. 2016 Jul;33(7):511-22. doi: 10.1007/s40266-016-0382-1. Drugs Aging. 2016. PMID: 27357173 Free PMC article.
Different Risk Profiles for Progression of Nonproliferative Diabetic Retinopathy: A 2-Year Study.
Marques IP, Ribeiro ML, Santos TP, Mendes LG, Reste-Ferreira D, Santos AR, Lobo CL, Cunha-Vaz JG. Marques IP, et al. Ophthalmol Ther. 2023 Feb;12(1):485-500. doi: 10.1007/s40123-022-00623-7. Epub 2022 Dec 10. Ophthalmol Ther. 2023. PMID: 36495395 Free PMC article.
Modeling the economic impact of medication adherence in type 2 diabetes: a theoretical approach.
Cobden DS, Niessen LW, Rutten FF, Redekop WK. Cobden DS, et al. Patient Prefer Adherence. 2010 Sep 7;4:283-90. doi: 10.2147/ppa.s12121. Patient Prefer Adherence. 2010. PMID: 20859455 Free PMC article.
A forecasting model of disease prevalence based on the McKendrick-von Foerster equation.
Akushevich I, Yashkin A, Kravchenko J, Fang F, Arbeev K, Sloan F, Yashin AI. Akushevich I, et al. Math Biosci. 2019 May;311:31-38. doi: 10.1016/j.mbs.2018.12.017. Epub 2018 Dec 28. Math Biosci. 2019. PMID: 30597156 Free PMC article.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information